Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Myeloid Malignancies × magrolimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 3 Squamous Cell Carcinoma of Head and Neck 2 Colorectal Neoplasms 2 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Sezary Syndrome 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Myeloid Malignancies 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1

Interventions

venetoclax 1 magrolimab 1 cc-486 1 Mitoxantrone 1 Etoposide 1 Cytarabine 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04778410 2025-03-20

Study of Magrolimab Combinations in Participants With Myeloid Malignancies

Gilead Sciences

Phase 2 Terminated

54 enrolled 26 charts

Myeloid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡